Allspring Global Investments Holdings, LLC Neurocrine Biosciences Inc Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 689,986 shares of NBIX stock, worth $85.8 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
689,986
Previous 710,600
2.9%
Holding current value
$85.8 Million
Previous $97.8 Million
18.8%
% of portfolio
0.13%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
622Shares Held
95.2MCall Options Held
661KPut Options Held
221K-
Black Rock Inc. New York, NY14.2MShares$1.76 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.25 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$573 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$307 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$294 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...